EP1007062 - THERAPEUTIC USE OF HEMOGLOBIN TO TREAT HEAD INJURY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 27.08.2004 Database last updated on 31.08.2024 | Most recent event Tooltip | 27.08.2004 | Application deemed to be withdrawn | published on 13.10.2004 [2004/42] | Applicant(s) | For all designated states Baxter International Inc. One Baxter Parkway Deerfield, IL 60015 / US | [N/P] |
Former [2000/24] | For all designated states BAXTER INTERNATIONAL INC. One Baxter Parkway Deerfield, IL 60015 / US | Inventor(s) | 01 /
BURHOP, Kenneth, E. 1230 Regent Drive Mundelein, IL 60060 / US | 02 /
SHACKFORD, Steven, R. 10 Westview Lane Shelburne, VT 05482 / US | [2000/24] | Representative(s) | Bassett, Richard Simon, et al Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | [N/P] |
Former [2004/15] | Bassett, Richard Simon, et al Eric Potter Clarkson, Park View House, 58 The Ropewalk Nottingham NG1 5DD / GB | ||
Former [2000/24] | Baker, Colin John, et al Eric Potter Clarkson Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | Application number, filing date | 97945406.3 | 30.09.1997 | [2000/24] | WO1997US17673 | Priority number, date | US19960734296 | 21.10.1996 Original published format: US 734296 | [2000/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9817289 | Date: | 30.04.1998 | Language: | EN | [1998/17] | Type: | A1 Application with search report | No.: | EP1007062 | Date: | 14.06.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.04.1998 takes the place of the publication of the European patent application. | [2000/24] | Search report(s) | International search report - published on: | US | 30.04.1998 | (Supplementary) European search report - dispatched on: | EP | 20.08.2002 | Classification | IPC: | A61K35/14, A61K38/42, A61P43/00 | [2002/39] | CPC: |
A61K38/42 (EP,US);
A61P17/00 (EP);
A61P25/00 (EP);
A61P31/00 (EP);
A61P43/00 (EP)
|
Former IPC [2000/24] | A61K35/14, A61K38/16 | Designated contracting states | DE, FR, GB [2000/24] | Title | German: | THERAPEUTISCHE VERWENDUNG VON HÄMOGLOBIN ZUR BEHANDLUNG VON KOPFVERLETZUNGEN | [2000/24] | English: | THERAPEUTIC USE OF HEMOGLOBIN TO TREAT HEAD INJURY | [2000/24] | French: | UTILISATION THERAPEUTIQUE DE L'HEMOGLOBINE DANS LE TRAITEMENT DES LESIONS CEREBRALES | [2000/24] | Entry into regional phase | 15.04.1999 | National basic fee paid | 15.04.1999 | Search fee paid | 15.04.1999 | Designation fee(s) paid | 15.04.1999 | Examination fee paid | Examination procedure | 28.04.1998 | Request for preliminary examination filed International Preliminary Examining Authority: US | 15.04.1999 | Examination requested [2000/24] | 30.09.2003 | Despatch of a communication from the examining division (Time limit: M06) | 14.04.2004 | Application deemed to be withdrawn, date of legal effect [2004/42] | 14.05.2004 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/42] | Fees paid | Renewal fee | 03.09.1999 | Renewal fee patent year 03 | 04.09.2000 | Renewal fee patent year 04 | 24.09.2001 | Renewal fee patent year 05 | 23.09.2002 | Renewal fee patent year 06 | 24.09.2003 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9632130 (BAXTER INT [US]) [X] 1-25 *cf. abstract, page 2, lines 11-21, line 35 bridging with page 3, lines 1-18*; | [X] - COLE D J ET AL, "FOCAL CEREBRAL ISCHEMIA IN RATS EFFECT OF HYPERVOLEMIC HEMODILUTION WITH DIASPIRIN CROSS-LINKED HEMOGLOBIN VERSUS ALBUMIN ON BRAIN INJURY AND EDEMA", ANESTHESIOLOGY, AMERICAN SOCIETY OF ANESTHESIOLOGISTS, PHILADELPHIA, PA,, US, (199302), vol. 78, no. 2, ISSN 0003-3022, pages 335 - 342, XP001041008 [X] 1-25 *cf. abstract, page 341, left-sided col. 2nd para.* | [X] - COLE D J ET AL, "DIASPIRIN CROSSLINKED HEMOGLOBIN (DCLHB): EFFECT OF HEMODILUTION DURING FOCAL CEREBRAL ISCHEMIA IN RATS", ARTIFICIAL CELLS, BLOOD SUBSTITUTES, AND IMMOBILIZATION BIOTECHNOLOGY, MARCEL DEKKER INC, US, (1994), vol. 22, no. 3, ISSN 1073-1199, pages 813 - 818, XP002066050 [X] 1-25 *cf. abstract, page 814, para. 2, page 817, last para.* DOI: http://dx.doi.org/10.3109/10731199409117915 | [X] - J.E. CHAPPELL ET AL., "Diaspirin cross-linked hemoglobin resuscitation improves cerebral perfusion after head injury and shock", JOURNAL OF TRAUMA, (1996), vol. 41, no. 5, pages 781 - 788, XP001095507 [X] 1-25 *cf. abstract, page 787, left-sided col., last para.* DOI: http://dx.doi.org/10.1097/00005373-199611000-00003 | [X] - D.J. COLE, J.C. DRUMMOND ET AL., "Effect of oncotic pressure of diaspirin cross-linked hemoglobin (DCLHb) on brain injury after temporary focal cerebral ischemia in rats", ANESTHESIA & ANALGESIA, loma linda univ. ca, (1996), vol. 83, no. 2, pages 342 - 347, XP002208454 [X] 1-25 *cf. abstract, page 346, left-sided col., last para. bridging with right-sided col., 1st para.* DOI: http://dx.doi.org/10.1097/00000539-199608000-00024 | [X] - J.E. CHAPPELL ET AL., "Hemodilution with diaspirin-cross-linked hemoglobin lowers intracranial pressure, improves cerebral perfusion pressure, and reduces fluid requirement following head injury and shock", SURGICAL FORUM, (1995), vol. 46, no. 0, pages 569 - 571, XP002208455 [X] 1-25 *cf. abstract, page 571, last para., "discussion"* | [A] - S.M. COHN ET AL., "Diaspirin cross-linked hemoglobin resucitation of hemorrhage: comparison ofa blood substitute with hypertonic saline and isotonic saline", JOURNAL OF TRAUMA, (1995), vol. 39, no. 2, pages 210 - 217, XP002208456 [A] 1-25 *cf. abstract* DOI: http://dx.doi.org/10.1097/00005373-199508000-00005 | International search | [X] - SURGICAL FORUM, 1995, Vol. 46, No. 1, CHAPPELL J.E. et al., "Hemodilution with Diaspirin Cross-Linked Hemoglobin Lowers Intracranial Pressure, Improves Cerebral Perfusion Pressure and Reduces Fluid Requirement Following Head Injury and Shock", pages 569-571. | [X] - CAN. J. NEUR. SCI., 1993, Vol. 20, COLE D.J. et al., "Focal Cerebral Ischemia in Rats Effect of Hemodilution with Alpha-Alpha Cross-Linked Hemoglobin on Brain Injury and Edema", page 30-36. | [X] - ANESTH., February 1993, Vol. 8, No. 2, COLE D.J. et al., "Focal Cerebral Ischemia in Rats Effect of Hypervolemic Hemodilution with Diaspirin Cross-Linked Hemoglobin Versus Albumin on Brain Injury and Edema", pages 335-342. | [Y] - J. LAB. CLIN. MED., February 1991, Vol. 117, No. 2, PRZYBELSKI R.J. et al., "Cross-Linked Hemoglobin Solution as a Resuscitative Fluid After Hemorrhage in the Rat", pages 143-151. | [Y] - ANESTH. ANALG., 1992, Vol. 74, SCHELL R.M. et al., "Hemodilution During Cerebral Ischemia in Rats: Effects of Stroma-Free Hemoglobin on Blood Flow", S262. |